全文获取类型
收费全文 | 396634篇 |
免费 | 35951篇 |
国内免费 | 16278篇 |
专业分类
耳鼻咽喉 | 3877篇 |
儿科学 | 7133篇 |
妇产科学 | 4559篇 |
基础医学 | 66188篇 |
口腔科学 | 8779篇 |
临床医学 | 30368篇 |
内科学 | 66843篇 |
皮肤病学 | 7692篇 |
神经病学 | 24704篇 |
特种医学 | 8753篇 |
外国民族医学 | 161篇 |
外科学 | 29652篇 |
综合类 | 58338篇 |
现状与发展 | 79篇 |
一般理论 | 6篇 |
预防医学 | 17866篇 |
眼科学 | 5573篇 |
药学 | 48754篇 |
84篇 | |
中国医学 | 15292篇 |
肿瘤学 | 44162篇 |
出版年
2024年 | 324篇 |
2023年 | 6076篇 |
2022年 | 8135篇 |
2021年 | 15507篇 |
2020年 | 13916篇 |
2019年 | 12934篇 |
2018年 | 12742篇 |
2017年 | 13062篇 |
2016年 | 13771篇 |
2015年 | 15769篇 |
2014年 | 24106篇 |
2013年 | 26567篇 |
2012年 | 23671篇 |
2011年 | 26793篇 |
2010年 | 22154篇 |
2009年 | 22003篇 |
2008年 | 21981篇 |
2007年 | 21296篇 |
2006年 | 19195篇 |
2005年 | 17049篇 |
2004年 | 14634篇 |
2003年 | 12785篇 |
2002年 | 10320篇 |
2001年 | 8734篇 |
2000年 | 7199篇 |
1999年 | 6239篇 |
1998年 | 5177篇 |
1997年 | 4897篇 |
1996年 | 4240篇 |
1995年 | 4338篇 |
1994年 | 3891篇 |
1993年 | 3289篇 |
1992年 | 2779篇 |
1991年 | 2557篇 |
1990年 | 2082篇 |
1989年 | 1856篇 |
1988年 | 1744篇 |
1987年 | 1439篇 |
1986年 | 1317篇 |
1985年 | 2034篇 |
1984年 | 1934篇 |
1983年 | 1402篇 |
1982年 | 1464篇 |
1981年 | 1159篇 |
1980年 | 1019篇 |
1979年 | 829篇 |
1978年 | 590篇 |
1977年 | 465篇 |
1976年 | 445篇 |
1975年 | 304篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
91.
《Vaccine》2022,40(43):6201-6205
Systemic immunosuppressive therapy (IS) renders patients with inflammatory bowel disease (IBD) vulnerable to fulminant hepatitis B virus (HBV) infection. Seroprotection against HBV through a full vaccination scheme is preferably obtained before IS is initiated, but often conflicts with the clinical need to initiate therapy rapidly. Consequently, the vast majority of patients will use IS during booster vaccinations. In this retrospective cohort study, we examined the serological response after a modified vaccination schedule which includes an initial double dose of Fendrix in patients with IBD and compared the results with the serological responses of patients with IBD who received the standard schedule. Seroprotection rates were 86.2 % and 88.9 % in the modified and standard schedule groups respectively. One-third of patients obtained seroprotection after only one double dose vaccine. A double dose may be considered in patients with IBD at high short-term risk of HBV infection when a rapid protective response is warranted. 相似文献
92.
《Journal of infection and chemotherapy》2022,28(12):1639-1644
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Wuhan in December 2019, and has since caused a global pandemic. The efficacy of several drugs has been evaluated, and it is now evident that tocilizumab has a beneficial effect, especially combined with corticosteroids, in patients with Coronavirus Disease 2019 (COVID-19). However, the optimal timing of tocilizumab administration has not yet been established. The goal of the present study was to determine the optimal timing of tocilizumab administration after starting corticosteroid therapy in patients with COVID-19.MethodsWe retrospectively analyzed the clinical characteristics of patients who were hospitalized for COVID-19 and treated with tocilizumab and corticosteroids in our hospital. The patients were divided into concurrent and sequential groups. The concurrent group received tocilizumab ≤24 h after corticosteroids, and the sequential group received tocilizumab >24 h after corticosteroid administration.ResultsThe baseline clinical characteristics of tocilizumab administration were similar between the two groups. White blood cell counts were significantly lower and C-reactive protein levels were significantly higher in the concurrent group than the sequential group. In the concurrent group, tocilizumab administration led to a significant decrease in maximum body temperature. In addition, there were significantly more oxygen-free days in the concurrent group than in the sequential group. However, survival rate was not significantly different between the concurrent and the sequential groups.ConclusionsIn the combination therapy with tocilizumab and corticosteroids, early administration of tocilizumab after starting corticosteroid treatment is effective when treating COVID-19. 相似文献
93.
目的 银椴苷(Tiliroside,Tle)是一种天然产物,存在于结香花(Edgeworthia chrysantha Lindl.)、金英(Galphimia gracilis)、和Phlomoides spectabilis等生物体中。本文主要探讨Tle对脂多糖(lipopolysaccharide,LPS)激活的原代小胶质细胞的M1/M2极化的转化作用及其抑制神经炎症反应的影响。方法 MTT检测各浓度Tle对LPS激活的原代小胶质细胞活性的影响;Griess试剂检测LPS激活的原代小胶质细胞的一氧化氮(Nitric oxide,NO)产物生成量的影响;ELISA法检测Tle对LPS激活的原代小胶质细胞的肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)蛋白水平的影响;qRT-PCR检测Tle对LPS激活的原代小胶质细胞的精氨酸酶-1(Arginase-1,Arg-1)和胰岛素生长因子-1(Insulin growth factor-1,IGF-1)的mRNA表达水平。结果 Tle(0-80 μmol·L-1)对LPS激活的原代小胶质细胞活性没有明显影响;Tle显著降低LPS激活的原代小胶质细胞亚硝酸盐的含量,并对炎症因子IL-6、TNF-α蛋白水平有显著抑制作用,同时显著提高抗炎因子Arg-1和IGF-1的mRNA水平。结论 Tle能够通过促进LPS激活的原代小胶质细胞M1型向M2型转化从而抑制神经炎症反应,因此Tle具有一定的神经保护作用。 相似文献
94.
目的筛选成骨型骨肉瘤与正常成骨细胞的差异表达基因, 寻找成骨型骨肉瘤发生、发展的关键基因。方法从Gene Expression Omnibus(GEO)数据库获得正常成骨细胞和骨肉瘤组织的基因表达数据集GSE33382, 采用R语言的limma包筛选正常成骨细胞和成骨型骨肉瘤的差异表达基因, 对差异表达基因进行京都基因与基因组百科全书(KEGG)通路富集分析。采用String数据库构建蛋白交互网络, 应用Cytoscape软件的分子复合物检测(MCODE)插件筛选互作网络中的网络模块, 应用Cytoscape软件中的BiNGO模块对MCODE筛选得到的前3个主要模块所包含的差异表达基因进行基因本体(GO)富集分析。采用MCC算法筛选蛋白互作网络中前10个关键基因。从GEO数据库获得骨肉瘤的基因表达和生存数据集GSE39055, 采用Kaplan-Meier法进行生存分析。选取2005年1月至2015年12月福建医科大学附属第一医院收治的48例成骨型骨肉瘤患者的资料进行验证, 采用免疫组化法测定骨肉瘤组织中STC2蛋白的表达, 结合患者的临床资料进行生存分析。结果从GSE33382数据集... 相似文献
95.
目的:探索携带CTLA-4 siRNA的适配子偶联脂质体颗粒是否可以激活肿瘤部位的抗肿瘤免疫反应,抑制肾细胞癌的生长。方法:采用薄膜水化法制备脂质体;使用透射电子显微镜观察脂质体的形态和结构;用Zetasizer测量Zeta电位;共孵育实验观察靶细胞对Lipo-siRNA的摄取;qPCR检测Lipo-siRNA对CTLA-4基因的沉默;小鼠移植瘤模型检测Lipo-siRNA的体内抑瘤能力;流式细胞术检测肿瘤浸润T细胞的激活状态;免疫荧光法检测肿瘤浸润T细胞的数目。结果:成功制备Lipo-siRNA,电镜结果显示其具有双层球状结构;Zetasizer测得其Zeta电位为(+20.53±2.66)mV;荧光显微镜观察结果表明Lipo-siRNA可以被靶细胞有效摄取,qPCR检测Lipo-siRNA可以显著降低CTLA-4基因的表达(P<0.001);小鼠移植瘤模型显示Lipo-siRNA较对照组而言可以显著抑制肿瘤生长(P<0.001),降低肿瘤细胞中CTLA-4的表达(P<0.001),提升肿瘤浸润T细胞的数量(P<0.000 1),并且提高了肿瘤浸润T细胞中IL-2(P<0.000 1)和IFN-γ(P<0.000 1)的表达水平。结论:适配子偶联脂质体可以携带CTLA-4 siRNA靶向肿瘤细胞,激活肿瘤部位的抗肿瘤免疫反应,抑制肿瘤的生长,对肾细胞癌的治疗具有潜在的临床应用价值。 相似文献
96.
97.
98.
《Diagnostic Histopathology》2022,28(9):399-405
Temporal artery biopsy is recommended for diagnosis of suspected giant cell arteritis, a systemic vasculitis of older adults. There is currently no formal consensus for histological interpretation of the biopsies. Typical histological findings include a transmural lymphocytic infiltrate with a population of macrophages resulting in destruction of the internal elastic lamina. However, it is a patchy process and multiple tissue levels must be examined. It is important to be aware of various subtle features that may lead to a diagnosis of arteritis, and immunohistochemistry can be helpful in some cases. Some biopsies show unusual features that could raise a differential diagnosis of alternative vasculitides. When there is no evidence of arteritis in a specimen, there are often non-specific features seen in the context of age-related changes. All of these histological patterns require close clinicopathological correlation to ensure correct interpretation. 相似文献
99.
100.